Page 28 - GTM-2-2

Global Translational Medicine Use of cardio biomarker in diagnosis of AMI

Seyler, 375: 81–88. 30. Bayes-Genis A, Conover CA, Schwartz RS, 2000, The
insulin-like growth factor axis: A review of atherosclerosis
https://doi.org/10.1515/bchm3.1994.375.2.81
and restenosis. Circ Res, 86: 125–130.
20. Hazell LJ, Baernthaler G, Stocker R, 2001, Correlation
between intima-to-media ratio, apolipoprotein B-100, https://doi.org/10.1161/01.res.86.2.125
myeloperoxidase, and hypochlorite-oxidized proteins in 31. Nishikimi T, Asakawa H, Iida H, et al., 2004, Different
human atherosclerosis. Free Radic Biol Med, 31: 1254–1262. secretion patterns of two molecular forms of cardiac
https://doi.org/10.1016/s0891-5849(01)00717-1 adrenomedullin in pressure-and volume-overloaded human
heart failure. J Card Fail, 10: 321–327.
21. Kutter D, Devaquet P, Vanderstocken G, et al., 2000,
Consequences of total and subtotal myeloperoxidase https://doi.org/10.1016/j.cardfail.2003.12.002
deficiency: Risk or benefit ? Acta Haematol, 104: 10–15. 32. Miyao Y, Nishikimi T, Goto Y, et al., 1998, Increased plasma
https://doi.org/10.1159/000041062 adrenomedullin levels in patients with acute myocardial
infarction in proportion to the clinical severity. Heart,
22. Nikpoor B, Turecki G, Fournier C, et al., 2001, A functional 79: 39–44.
myeloperoxidase polymorphic variant is associated with
coronary artery disease in French-Canadians. Am Heart J, https://doi.org/10.1136/hrt.79.1.39
142: 336–339. 33. Mohan G, Kaur R, Singh T, 2017, Cardiac biomarkers
https://doi.org/10.1067/mhj.2001.116769 in acute coronary syndrome. Curr Trends Diagn Treat,
1: 80–88.
23. Pecoits-Filho R, Stenvinkel P, Marchlewska A, et al., 2003, A
functional variant of the myeloperoxidase gene is associated https://doi.org/10.5005/jp-journals-10055-0019
with cardiovascular disease in end-stage renal disease 34. Duma RJ, Siegel AL, 1965, Serum creatinine phosphokinase
patients S-172. Kidney Int Suppl, 63: S172–S176. in acute myocardial infarction: Diagnostic value. Arch Intern
https://doi.org/10.1046/j.1523-1755.63.s84.32.x Med, 115: 443–451.

24. Brennan ML, Penn MS, Van Lente F, et al., 2003, Prognostic https://doi.org/10.1001/archinte.1965.03860160069011
value of myeloperoxidase in patients with chest pain. N Engl 35. Itoi K, Jiang YQ, Iwasakiz Y, et al., 2004, Regulatory
J Med, 17: 1595–1604. mechanisms of corticotropin-releasing hormone and
https://doi.org/10.1056/NEJMoa035003 vasopressin gene expression in the hypothalamus.
J Neuroendocrinol, 16: 348–355.
25. Baldus S, Heeschen C, Meinertz T, et al., 2003,
Myeloperoxidase serum levels predict risk in patients with https://doi.org/10.1111/j.0953-8194.2004.01172.x
acute coronary syndromes. Circulation, 108: 1440–1445. 36. Gheorghiade M, Gattis WA, O’Connor CM, et al., 2004,
https://doi.org/10.1161/01.CIR.0000090690.67322.51 Effects of tolvaptan, a vasopressin antagonist, in patients
hospitalized with worsening heart failure: A randomized
26. Wang W, Schulze CJ, Suarez-Pinzon WL, et al., 2002, controlled trial. JAMA, 291: 1963–1971.
Intracellular action of matrix metalloproteinase-2 accounts
for acute myocardial ischemia and reperfusion injury. https://doi.org.10.1001/jama.291.16.1963
Circulation, 106: 1543–1549. 37. Abraham WT, Shamshirsaz AA, McFann K, et al., 2006,
https://doi.org/10.1161/01.cir.0000028818.33488.7b Aquaretic effect of lixivaptan, an oral, non-peptide, selective
v2 receptor vasopressin antagonist, in New York Heart
27. Kwan JA, Schulze CJ, Wang W, et al., 2004, Matrix Association functional class II and III chronic heart failure
metalloproteinase-2 (MMP-2) is present in the nucleus of patients. J Am Coll Cardiol, 47: 1615–1621.
cardiac myocytes and is capable of cleaving poly (ADP-
ribose) polymerase (PARP) in vitro. FASEB J, 18: 690–692. https://doi.org/10.1016/j.jacc.2005.11.071
https://doi.org/10.1096/fj.02-1202fje 38. Rezar R, Jirak P, Gschwandtner M, et al., 2020, Heart-
type fatty acid-binding protein (H-FABP) and its role as a
28. Morrow DA, Braunwald E, 2003, Future of biomarkers in biomarker in heart failure: What do we know so far? J Clin
acute coronary syndromes: Moving toward a multimarker Med, 9: 164.
strategy. Circulation, 108: 250–252.
https://doi.org/10.3390/jcm9010164
https://doi.org/10.1161/01.cir.0000078080.37974.d2
39. Atay E, Guzel M, Amanvermez R, et al., 2019, Role of
29. Lund J, Qin QP, Ilva T, et al., 2003, Circulating pregnancy-
associated plasma protein a predicts outcome in patients Gal-3 and H-FABP in the early diagnosis of acute coronary
with acute coronary syndrome but no troponin I elevation. syndrome. Bratisl Lek Listy, 120: 124–130.
Circulation, 108: 1924–1926. https://doi.org/10.4149/bll_2019_020
https://doi.org/10.1161/01.cir.0000096054.18485.07 40. Levin ER, Gardner DG, Samson WK, 1998, Natriuretic

Volume 2 Issue 2 (2023) 10 https://doi.org/10.36922/gtm.0403